China BE study [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-08-29 12:34 (2142 d 14:06 ago) – Posting: # 20529
Views: 4,661

Hi Ajit,

please follow the Forum’s Policy.

❝ Can we submit USFDA approved ANDA dossier to CFDA for drug Registration


You can submit everything but the chance for acceptance is close to nil.

❝ […] we need to do Fresh BE study in chinese population


Correct. Like most jurisdictions the National Medical Products Administration, Center for Drug Evaluation (NMPA, CDE) – formerly the China Food and Drug Administration or CFDA – requires the local reference product in the study.* Only if the innovator’s product is not approved in China, one can use the major market’s corresponding product.

There are some more differences to the FDA’s requirements to observe:


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,430 posts in 4,931 threads, 1,674 registered users;
36 visitors (0 registered, 36 guests [including 8 identified bots]).
Forum time: 02:41 CEST (Europe/Vienna)

It has yet to be proven
that intelligence has any survival value.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5